International Journal of Clinical Research

Objective To retrospectively analyze the value of thrombolytic therapy combined with anticoagulation in emergency patients with severe pulmonary thromboembolism. Methods the data of 30 patients with acute severe pulmonary thromboembolism who received anticoagulant therapy in our hospital from March 2019 to March 2020 were collected retrospectively, the data of 30 patients who received anticoagulation and thrombolytic therapy in our hospital from April 2020 to April 2020 were 2021 as Observation Group Results before treatment, there was no significant difference in heart rate, respiration and pulmonary hypertension between the two groups (P > 0.05) . After nursing, the indexes in the observation group were better than those in the control group, and the bleeding rate was lower than that in the control group (p < 0.05). Conclusion thrombolytic therapy combined with anticoagulation can stabilize the vital signs of patients with severe pulmonary thromboembolism, improve pulmonary perfusion, and reduce the bleeding rate.

Thrombolysis; Anticoagulant therapy; Emergency severe pulmonary thromboembolism; Pulmonary perfusion; Warfarin; Low molecular weight heparin